Thymosin Alpha-1 vs Thymalin: A Research Comparison
Thymosin Alpha-1 and Thymalin are both studied within thymic-peptide and immune-signaling research, but they differ in composition. Thymosin Alpha-1 is a single, well-defined 28-residue peptide; Thymalin is a heterogeneous thymus-derived polypeptide extract with no single molecular formula. Their regulatory histories also differ, with Thymosin Alpha-1 marketed in several countries and Thymalin used in Russian clinical practice. The canonical difference is defined peptide versus extract. Both are supplied for research use only.
The core difference: defined peptide vs extract
The defining distinction is molecular definition. Thymosin Alpha-1 is a single, characterized 28-amino-acid, N-terminally acetylated peptide with one sequence and one molecular formula, which makes it reproducible from lot to lot. Thymalin is a thymus-derived polypeptide fraction, a heterogeneous extract of multiple peptides rather than one molecule, so its composition is defined by its preparation rather than a single formula. The two are studied in the same broad immune area but should not be treated as equivalents.
Structure and molecular profile
Thymosin Alpha-1 (molecular weight near 3108.3 g/mol) is a defined single-molecule peptide with a known sequence. Thymalin, as a heterogeneous extract, has no single molecular formula, weight, or sequence, and its composition is documented on the Certificate of Analysis for each preparation. Thymalin should also not be confused with the defined synthetic nonapeptide Thymulin, which is a separate molecule.
Clinical and regulatory context
Thymosin Alpha-1 (thymalfasin) is approved and marketed in a number of countries under the brand name Zadaxin, where it has been used for indications such as chronic hepatitis B, and has been studied in human clinical research as an immune-modulating peptide, though it is not FDA-approved in the United States. Thymalin has been used in Russian clinical research and practice as a thymic polypeptide preparation. Those statements describe regulated or nationally used products; the Thymosin Alpha-1 and Thymalin supplied here are research-use-only materials, not approved medicines.
How each is studied
Both are studied within immune-signaling and thymic-peptide biology. Thymosin Alpha-1 offers a single defined molecule for reproducible characterization of a specific sequence, while Thymalin is studied as a thymic polypeptide fraction where the extract as a whole is the object of interest. A protocol chooses the defined peptide when reproducibility and a known structure matter, and the extract when the thymic fraction itself is the research subject.
All products are intended strictly for in-vitro laboratory research and development use only. Not for human or veterinary use, not a drug, food, or cosmetic, and not intended to diagnose, treat, cure, or prevent any disease.